Qube Research & Technologies (QRT)’s Biohaven BHVN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.5M	Sell	905,935 -634,510	-41%	-$6.83M	0.01%	1116
2026 Q1	$13M	Sell	1,540,445 -30,165	-2%	-$330K	0.01%	1122
2025 Q4	$17.7M	Buy	1,570,610 +305,013	+24%	+$3.78M	0.02%	979
2025 Q3	$19M	Buy	1,265,597 +1,130,157	+834%	+$16.5M	0.02%	917
2025 Q2	$1.91M	Buy	+135,440	New	+$2.41M	﹤0.01%	2208
2024 Q3	–	Sell	-87,877	Closed	-$3.05M	–	3331
2024 Q2	$3.05M	Buy	87,877 +86,176	+5,066%	+$3.41M	﹤0.01%	1460
2024 Q1	$93K	Buy	+1,701	New	+$84.2K	﹤0.01%	3326
2023 Q4	–	Sell	-30,052	Closed	-$782K	–	4341
2023 Q3	$782K	Buy	+30,052	New	+$625K	﹤0.01%	1845

Other funds holding BHVN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

IAM

Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Qube Research & Technologies (QRT)'s BHVN Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its Biohaven (BHVN) stake by 41% in Q2 2026, selling an estimated $6.83M and leaving 905,935 shares worth $13.5M. The position accounts for 0.01% of the portfolio, ranked #1116.

Qube Research & Technologies (QRT) first reported a position in BHVN in Q3 2023 and has held it in 8 quarters since. The position peaked at $19M in Q3 2025. 292 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

Qube Research & Technologies (QRT) held 905,935 shares of Biohaven worth $13.5M as of Q2 2026.
Qube Research & Technologies (QRT) sold 634,510 Biohaven shares in Q2 2026, an estimated $6.83M.
Biohaven made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1116 holding.
Qube Research & Technologies (QRT) first reported a position in Biohaven in Q3 2023 and has held it in 8 quarters since.
Qube Research & Technologies (QRT)'s Biohaven position peaked at $19M in Q3 2025.
292 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.